Locations:
Search IconSearch
March 6, 2015/Neurosciences/Research

First Study of DBS for Thalamic Pain (Video)

Addressing the emotional component of post-stroke pain

15-CCC-143 SOTC Hero Image 690x380pxl

Andre Machado, MD, PhD, of Cleveland Clinic’s Neurological Institute, has completed the first human clinical trial of deep brain stimulation (DBS) for refractive thalamic pain syndrome. The study is also the first controlled study to assess the effects of DBS on the affective or emotional sphere of pain. Thalamic pain syndrome is a chronic condition that is usually caused by a stroke. Patients describe their pain as a constant burning or aching sensation, disabling in nature. Dr. Machado targeted a particular area of the brain that is a key node in the networks that process mood and behavior. The study was carried out entirely at Cleveland Clinic with funding from the NIH Director’s New Innovator Award. “Chronic pain is not only a somatosensory phenomenon,” says Dr. Machado. “Affective and cognitive spheres are equally important in the experience of pain and suffering. Our approach aims to alleviate the affective sphere of pain and thus reduce pain-related disability.”

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad